Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries
Articles published by Chartmill
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Triple Flag Precious Metals (NYSE:TFPM) Presents a High-Growth Momentum and Technical Setup Opportunity
↗
March 18, 2026
Via
Chartmill
Tickers
TFPM
CENCORA INC (NYSE:COR) Passes the "Caviar Cruise" Quality Investing Screen
↗
March 18, 2026
Via
Chartmill
Tickers
COR
Lincoln Electric Holdings (NASDAQ:LECO) Passes the "Caviar Cruise" Quality Investing Screen
↗
March 18, 2026
Via
Chartmill
Tickers
LECO
Sabesp (NYSE:SBS) Shows High-Grade Technical Setup for a Potential Breakout
↗
March 18, 2026
Via
Chartmill
Tickers
SBS
Taiwan Semiconductor (NYSE:TSM) Shows Strong Growth Momentum and Technical Setup
↗
March 18, 2026
Via
Chartmill
Tickers
TSM
Sprott Inc (NYSE:SII) Screened as a Top CAN SLIM Growth Stock
↗
March 18, 2026
Via
Chartmill
Tickers
SII
Autoliv Inc. (NYSE:ALV) Presents a Compelling Value Case with Strong Profitability
↗
March 18, 2026
Via
Chartmill
Tickers
ALV
SAP SE-SPONSORED ADR (NYSE:SAP) Emerges as a Quality Investment Candidate
↗
March 18, 2026
Via
Chartmill
Tickers
SAP
Advanced Micro Devices (NASDAQ:AMD) Presents a Compelling Growth at a Reasonable Price (GARP) Case
↗
March 18, 2026
Via
Chartmill
Tickers
AMD
Quanta Services Inc (NYSE:PWR) Passes the 'Caviar Cruise' Screen for Quality Investing
↗
March 18, 2026
Via
Chartmill
Tickers
PWR
ROYALTY PHARMA PLC-CL A (NASDAQ:RPRX) Shows High Technical and Setup Ratings Ahead of Potential Breakout
↗
March 18, 2026
Via
Chartmill
Tickers
RPRX
Market Breadth Analysis – Relief Rally Continues, But Internal Damage Is Still Visible
↗
March 18, 2026
Via
Chartmill
Tickers
IWM
QQQ
SPY
DT Midstream Inc (NYSE:DTM) Combines Minervini Trend Strength with High Growth Momentum
↗
March 18, 2026
Via
Chartmill
Tickers
DTM
JOYY Inc. (NASDAQ:JOYY) Fits the Peter Lynch GARP Investment Philosophy
↗
March 18, 2026
Via
Chartmill
Tickers
JOYY
BWX Technologies Inc (NYSE:BWXT) Presents a Compelling Growth and Breakout Setup
↗
March 18, 2026
Via
Chartmill
Tickers
BWXT
Texas Instruments Inc (NASDAQ:TXN): A Quality Dividend Stock with Strong Fundamentals
↗
March 18, 2026
Via
Chartmill
Tickers
TXN
Perdoceo Education Corp (NASDAQ:PRDO) Presents a Compelling Value Case with Strong Fundamentals
↗
March 18, 2026
Via
Chartmill
Tickers
PRDO
ULTA BEAUTY INC (NASDAQ:ULTA) Passes Key Quality Investing Filter
↗
March 18, 2026
Via
Chartmill
Tickers
ULTA
Corcept Therapeutics Inc (NASDAQ:CORT): A GARP Pick with Accelerating Growth and a Solid Financial Base
↗
March 18, 2026
Via
Chartmill
Tickers
CORT
Liberty Live Holdings-A (NASDAQ:LLYVA) Fits the Minervini High-Growth Momentum Template
↗
March 18, 2026
Via
Chartmill
Tickers
LLYVA
Airlines Take Flight While Oil Burns: Markets Edge Higher Amid Middle East Tensions
↗
March 18, 2026
Via
Chartmill
Tickers
AMZN
AXP
DAL
LLY
NBIS
QCOM
Cibus Inc (NASDAQ:CBUS) Q4 2025 Earnings: Revenue Miss, Cash Concerns Overshadow Pipeline Progress
↗
March 17, 2026
Via
Chartmill
Tickers
CBUS
Andersen Group Inc (NYSE:ANDG) Posts Q4 Revenue Beat but Guides for 2026 GAAP Loss
↗
March 17, 2026
Via
Chartmill
Tickers
ANDG
QFIN Holdings Inc (NASDAQ:QFIN) Reports Mixed Q4 Results Amid Headwinds; Shares Fall
↗
March 17, 2026
Via
Chartmill
Tickers
QFIN
Which S&P500 stocks are showing activity after the closing bell on Tuesday?
↗
March 17, 2026
Via
Chartmill
Tickers
CF
ELV
IR
LOW
NXPI
SHW
ClearPoint Neuro Inc (NASDAQ:CLPT) Reports Q4 2025 Revenue Beat Amid Widened Loss, Shares Fall
↗
March 17, 2026
Via
Chartmill
Tickers
CLPT
Oklo Inc. (NYSE:OKLO) Reports Q4 2025 Results with Wider Loss, Focuses on Regulatory Progress
↗
March 17, 2026
Via
Chartmill
Tickers
OKLO
Stay updated with the stocks that are on the move in today's after-hours session.
↗
March 17, 2026
Via
Chartmill
Tickers
AKTX
CNEY
DVLT
ELV
FLD
HIT
Kestra Medical Technologies (NASDAQ:KMTS) Reports Q3 Revenue Beat but Stock Falls on In-Line Losses
↗
March 17, 2026
Via
Chartmill
Tickers
KMTS
Trevi Therapeutics Inc. (NASDAQ:TRVI) Beats Q4 2025 EPS Estimates, Gains FDA Alignment for Phase 3 Program
↗
March 17, 2026
Via
Chartmill
Tickers
TRVI
< Previous
1
2
3
4
5
6
7
8
9
...
99
100
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.